ASND
Ascendis Pharma ASNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.59B
P/E Ratio
25.48
EPS
$8.73
Beta
0.48
52W High
$250.74
52W Low
$160.86
50-Day MA
$231.82
200-Day MA
$217.04
Dividend Yield
—
Profit Margin
57.30%
Forward P/E
13.30
PEG Ratio
—
About Ascendis Pharma AS
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
Fundamentals
| Revenue (TTM) | $865.78M |
| Gross Profit (TTM) | $770.87M |
| EBITDA | $-10.22M |
| Operating Margin | 10.10% |
| Return on Equity | 33.30% |
| Return on Assets | -0.60% |
| Revenue/Share (TTM) | $14.19 |
| Book Value | $9.06 |
| Price-to-Book | 25.15 |
| Price-to-Sales (TTM) | 16.85 |
| EV/Revenue | 14.53 |
| EV/EBITDA | -20.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 144.30% |
| Shares Outstanding | $65.58M |
| Float | $62.11M |
| % Insiders | 0.82% |
| % Institutions | 110.56% |
Historical Volatility
HV 10-Day
37.82%
HV 20-Day
46.59%
HV 30-Day
48.04%
HV 60-Day
42.54%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($296.88 target)
4
Strong Buy13
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026